Six cases of clinically functional glucagon-producing neuroendocrine tumors of the pancreas were identified (for an estimated prevalence of glucagonomas among all resected functioning and non-functioning PanNETs in the institutions: 0.5%). The gene discussed is GCG; the disease is pancreatic neuroendocrine tumor.